Gene mutations should be tested routinely for ovarian cancer, say scientists

Credit: Unsplash/CC0 Public Domain

Scientists from The University of Manchester have shown that testing for two gene families linked to a lifetime epithelial ovarian cancer risk of between 5% and 20% has a much higher than expected detection rate.

Routine testing for mutations in homologous recombination (HR) and mismatch repair (MMR) genes in women with the disease who also have a family history of ovarian, breast and other cancers, would save lives, they say.

The study, published in the journal Genetics in Medicine, is the largest study of cancer causing genetic…

Continue Reading


News Source: https://medicalxpress.com/news/2022-10-gene-mutations-routinely-ovarian-cancer.html